dexmedetomidine accord
accord healthcare s.l.u. - dexmedetomidine - premedication - psicholeptikai - už sedacija suaugusiųjų icu (intensyvios slaugos skyrių) pacientams, kuriems reikalingas tam sedacija lygis ne giliau nei susijaudinimą, reaguodama į žodinis stimuliacija (atitinkamai į richmond, sujaudinimas-sedacija masto (rass) nuo 0 iki -3). už sedacija ne intubated suaugusiems pacientams prieš ir (arba) atliekant diagnostines ar chirurgines procedūras, reikalaujančias sedacija, i. procesinių/miega, sedacija.
dexmedetomidine b. braun
b.braun melsungen ag - deksmedetomidinas - koncentratas infuziniam tirpalui - 100 µg/ml - dexmedetomidine
dexmedetomidine teva
teva b.v. - deksmedetomidinas - koncentratas infuziniam tirpalui - 100 µg/ml - dexmedetomidine
orladeyo
biocryst ireland limited - berotralstat dihydrochloride - angioedema, paveldima - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.
byfavo
paion deutschland gmbh - remimazolam besilate - sąmoningas sedavimas - psicholeptikai - remimazolam is indicated in adults for procedural sedation. remimazolam 50 mg is indicated in adults for intravenous induction and maintenance of general anaesthesia.
dexmedetomidine kabi
fresenius kabi polska sp.z.o.o. - deksmedetomidinas - koncentratas infuziniam tirpalui - 100 µg/ml - dexmedetomidine
paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.
tavneos
vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - imunosupresantai - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).
lumykras
amgen europe bv - sotorasib - karcinoma, nesmulkiųjų ląstelių skausmas - antinavikiniai vaistai - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.
pyrukynd
agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.